Hamilton Thorne Announces the Acquisition of Tek-Event Pty Ltd.
Expands the Company's proprietary product offerings with the addition of Tek-Event's Cell-Tek Microscope Chamber
Provides a direct sales and support platform for the entire Hamilton Thorne product portfolio in Australia
BEVERLY, Mass. and TORONTO, May 04, 2021 (GLOBE NEWSWIRE) --
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it has completed the acquisition of Tek-Event Pty Ltd.
Tek-Event, based in suburban Sydney, Australia, is the manufacturer of the Cell-Tek Microscope Chamber, a specialized product for controlling temperature, air flow, humidification, and air quality that is used in ART and laboratory markets worldwide. The Cell-Tek Chamber is designed to create an optimum environment for visually examining, manipulating, transferring, or assessing oocytes and embryos for in-vitro fertilization (IVF). Tek-Event is also a value-added reseller of a select range of capital equipment and consumables, including those manufactured by Hamilton Thorne. Tek-Event serves approximately 90% of IVF clinics in Australia.
Acquisition Details
Hamilton Thorne acquired the capital stock of Tek-Event Pty Ltd. for a purchase price of approximately A$1.1 million (approximately US$860,000), plus closing adjustments, paid at closing, with the potential for the payment of additional purchase price of up to approximately A$590,000 (approximately US$460,000), based on achieving certain financial targets. The purchase price paid at closing is equal to approximately 1.15 times Tek-Event's annualized nine-month sales for its fiscal year ending June 30, 2021.
"This acquisition represents a unique opportunity to add a high-quality product line with significant growth potential to our product portfolio, as well as to establish a direct sales presence in Australia," stated David Wolf, President and CEO of Hamilton Thorne. "While this is a relatively small transaction, it is strategic and accretive. In addition to this transaction, we have an active pipeline and are actively working on multiple opportunities. We are mindful, however, that acquisition completion is hard to predict and the effects of the Covid-19 pandemic could affect this goal."
Key Benefits of the Transaction:
-- Addition of the Cell-Tek Microscope Chamber, a premium product that diversifies and increases Hamilton Thorne's product offerings to the ART laboratory -- Provides a direct sales and support platform for the entire Hamilton Thorne portfolio of products in Australia -- Opportunity to increase Cell-Tek Microscope Chamber sales by leveraging Hamilton Thorne's established worldwide sales and marketing resources -- Non-dilutive transaction financed through its cash on hand -- Expected to be accretive to revenue and Adjusted EBITDA in 2021
Tek-Event will operate as a part of Hamilton Thorne's Planer Limited subsidiary and will retain its brand identity and all personnel. Additional information on Tek-Event and the Cell-Tek Microscope Chamber can be found at https://tekevent.com.
About
Hamilton Thorne Ltd. (www.hamiltonthorne.ltd)